Randomized Controlled Trial
Copyright ©The Author(s) 2023.
World J Gastroenterol. Aug 21, 2023; 29(31): 4783-4796
Published online Aug 21, 2023. doi: 10.3748/wjg.v29.i31.4783
Figure 3
Figure 3 Effect of poly(A)-specific ribonuclease on esophageal cancer cell proliferation, migration and invasion, cell cycle, and cell apoptosis in vitro. A and B: The interference efficiency of poly(A)-specific ribonuclease (PARN) via shRNA; C: Representative images of the Celigo cell count assay (magnification, × 100) and cumulative data of cell numbers in TE-1 and Eca-109 cells transfected with control shRNA or PARN shRNA; D: Representative images and statistical analysis of the wound healing assay; E: Representative images and statistical analysis of the transwell assay; F and G: Representative images and statistical analysis of flow cytometry analysis of TE-1 and Eca-109 cells after transfection. Cell cycle analysis revealed that PARN affected TE-1 and Eca-109 cell proliferation (F), and cell apoptosis analysis showed that PARN affected the apoptosis of TE-1 and Eca-109 cells (G). aP < 0.05, bP < 0.01, aP < 0.0001, cP < 0.001, means ± SDs are shown. sh PARN: Poly(A)-specific ribonuclease shRNA; sh-NC: Control shRNA.